Outsourcing

Latest News


Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

The author discusses the upcoming human research congressional debate and CROs' preparations to respond.

The author discusses recent acquisition activity in the chemistry, manufacturing, and controls (CMC) outsourcing industry.

The author discusses the current soft demand and excess capacity in the contract-manufacturing market of small molecule actives and intermediates.

Capacity is a pivotal commodity in the contract manufacturing business. If you have enough of the right kind of capacity, it's like platinum; conversely, too much of the wrong kind of capacity is like tin.

Contract service providers and clients alike must be realistic and forthcoming about their expectations to accomplish a truthful outsourcing partnership.

The 2001 POMA Sourcing Survey declares 2001 a good year for drug development and manufacturing outsourcing.

The consolidation of the contract manufacturing industry has spread to the parenteral fill-finish segment, with two deals announced just before this year's Fourth of July holiday.